atracurium besylate


Also found in: Dictionary, Wikipedia.

a·tra·cu·ri·um be·syl·ate

(a-tră-kyūr'ē-ŭm bē'sil-āt'),
A nondepolarizing neuromuscular relaxant of intermediate duration of action; used as an adjunct to general anesthesia; a curarelike agent.

atracurium besylate

Anesthesiology An injectable intermediate-acting nondepolarizing muscle relaxing anesthetic used with general anesthetics in Pts undergoing surgery or mechanical ventilation where skeletal muscle relaxation is required. See Cisatracurium, Muscle relaxant, Nondepolarizing agent. Cf Depolarizing agent.

atracurium besylate

a short-acting, nondepolarizing neuromuscular blocking agent.
References in periodicals archive ?
Atracurium besylate solution for injection 10 mg / ml vial or ampoule of 2.
Eventually it was presented as a besylate salt and produced for clinical testing as atracurium besylate, an aqueous solution of 10 mg/ml.
has announced approvals for etodolac tablets, captopril tablets, preserved and unpreserved presentations of atracurium besylate injection, acyclovir injection, acyclovir tablets and pentoxifylline tablets.
has announced approvals for etodolac tablets, preserved and unpreserved presentations of atracurium besylate injection, captopril tablets, acyclovir injection and acyclovir tablets.
Atracurium Besylate 10mg/ml (Required 2000 Vials/ Amps 1 X 2.
has announced approvals for etodolac tablets, captopril tablets, and preserved and unpreserved presentations of atracurium besylate injection.
has announced approvals for etodolac tablets and preserved and unpreserved presentations of atracurium besylate injection.
has announced approvals for etodolac tablets, 400 mg and preserved and unpreserved presentations of atracurium besylate injection.
has received approvals from the FDA to market both preserved and unpreserved presentations of atracurium besylate injection, it was announced today by Richard F.
Food and Drug Administration has approved atracurium besylate injection, a neuromuscular blocking agent, for marketing by Ohmeda, a global market leader in anesthesia and critical care.
Atracurium besylate is an injectable nondepolarizing skeletal muscle relaxant used as an adjunct to general anesthesia in the treatment of patients undergoing surgery or mechanical ventilation to provide skeletal muscle relaxation.